{"id":"https://openalex.org/W2022160610","doi":"https://doi.org/10.1002/cncr.11656","title":"Combined trastuzumab and paclitaxel treatment better inhibits ErbB\u20102\u2010mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone","display_name":"Combined trastuzumab and paclitaxel treatment better inhibits ErbB\u20102\u2010mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone","publication_year":2003,"publication_date":"2003-08-12","ids":{"openalex":"https://openalex.org/W2022160610","doi":"https://doi.org/10.1002/cncr.11656","mag":"2022160610","pmid":"https://pubmed.ncbi.nlm.nih.gov/14508823"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.11656","doi":"https://doi.org/10.1002/cncr.11656","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.11656","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11656","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11656","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044185045","display_name":"Kristine S. Klos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristine S. Klos","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA","Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101811862","display_name":"Xiaoyan Zhou","orcid":"https://orcid.org/0000-0001-5999-7237","observed_orcids":["https://orcid.org/0000-0001-5999-7237","https://orcid.org/0000-0001-5489-8301"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoyan Zhou","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087797167","display_name":"Sangkyou Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sangkyou Lee","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091864599","display_name":"Lianglin Zhang","orcid":"https://orcid.org/0009-0009-7781-3118","observed_orcids":["https://orcid.org/0009-0009-7781-3118"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lianglin Zhang","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022094369","display_name":"Wentao Yang","orcid":"https://orcid.org/0000-0001-7712-822X","observed_orcids":["https://orcid.org/0000-0001-7712-822X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wentao Yang","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102149738","display_name":"Yoichi Nagata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoichi Nagata","raw_affiliation_strings":["Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040450464","display_name":"Dihua Yu","orcid":"https://orcid.org/0000-0001-6231-9381","observed_orcids":["https://orcid.org/0000-0001-6231-9381"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dihua Yu","raw_affiliation_strings":["","Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040450464"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I919571938"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":3.6675,"has_fulltext":true,"cited_by_count":109,"citation_normalized_percentile":{"value":0.93184572,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"98","issue":"7","first_page":"1377","last_page":"1385"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9042999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.09309999644756317,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/erbb2","display_name":"ERBB2","score":0.8669999837875366},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7039999961853027},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7850000262260437},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.8080000281333923},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.7369999885559082},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/tumor-microvessel-density","display_name":"tumor microvessel density","score":0.8309999704360962},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.8299999833106995},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8100000023841858},{"id":"https://openalex.org/keywords/endothelial-cell-migration","display_name":"endothelial cell migration","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7839999794960022},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.5389999747276306},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.4560000002384186},{"id":"https://openalex.org/keywords/scid-mice","display_name":"SCID mice","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8802688717842102},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.850692868232727},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8300284147262573},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5986474752426147},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4500194787979126},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.43988409638404846},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4299652576446533},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4223266541957855},{"id":"https://openalex.org/C3018521938","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast carcinoma","level":4,"score":0.41495558619499207},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3455580472946167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3404303789138794},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3238389492034912},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31411218643188477}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011336","descriptor_name":"Probability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.11656","doi":"https://doi.org/10.1002/cncr.11656","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.11656","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11656","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:14508823","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14508823","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1002/cncr.11656","doi":"https://doi.org/10.1002/cncr.11656","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.11656","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11656","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2088269972","display_name":null,"funder_award_id":"R01-CA60448","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4195537894","display_name":"TRAINING IN CANCER BIOLOGY","funder_award_id":"T32CA060440","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2022160610.pdf","grobid_xml":"https://content.openalex.org/works/W2022160610.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W23465562","https://openalex.org/W142377240","https://openalex.org/W167845783","https://openalex.org/W222594567","https://openalex.org/W1595219556","https://openalex.org/W1595263809","https://openalex.org/W1797447800","https://openalex.org/W1867197625","https://openalex.org/W1882520884","https://openalex.org/W1976033985","https://openalex.org/W1978139448","https://openalex.org/W1985712533","https://openalex.org/W1988307856","https://openalex.org/W2028387622","https://openalex.org/W2034801324","https://openalex.org/W2042204791","https://openalex.org/W2044868069","https://openalex.org/W2052512448","https://openalex.org/W2054728198","https://openalex.org/W2061202003","https://openalex.org/W2064297621","https://openalex.org/W2076746552","https://openalex.org/W2086619383","https://openalex.org/W2088388419","https://openalex.org/W2092229345","https://openalex.org/W2095156669","https://openalex.org/W2104316189","https://openalex.org/W2108410343","https://openalex.org/W2136166098","https://openalex.org/W2137672355","https://openalex.org/W2141393790","https://openalex.org/W2142786915","https://openalex.org/W2159256537","https://openalex.org/W2165845069","https://openalex.org/W2264655007","https://openalex.org/W2285386092","https://openalex.org/W2319962899","https://openalex.org/W2804842145"],"related_works":["https://openalex.org/W1590668690","https://openalex.org/W2326757487","https://openalex.org/W2031695016","https://openalex.org/W2128230789","https://openalex.org/W2124748060","https://openalex.org/W2032699899","https://openalex.org/W7133071283","https://openalex.org/W2168057516","https://openalex.org/W2808425084","https://openalex.org/W2108244538"],"abstract_inverted_index":{"BACKGROUND:":[0],"Trastuzumab":[1],"(Herceptin;":[2],"Genentech,":[3],"South":[4],"San":[5],"Francisco,":[6],"CA)":[7],"is":[8],"a":[9,122,205,218,258],"humanized":[10],"anti-ErbB-2":[11],"monoclonal":[12],"antibody":[13],"that":[14,37],"has":[15],"demonstrated":[16],"antitumor":[17],"function,":[18],"especially":[19],"in":[20,33,54,64,92,158,277,295,405],"combination":[21,123,177,344],"with":[22,35,104,114,172,185,188,202,215,237,257,287,309,321,384],"other":[23,386],"chemotherapies":[24],"such":[25,47],"as":[26,48],"paclitaxel":[27,84,176,216,313,381,392],"(Taxol;":[28],"Bristol":[29],"Myers-Squibb,":[30],"Princeton,":[31],"NJ),":[32],"patients":[34],"tumors":[36,256],"overexpress":[38],"ErbB-2.":[39],"Because":[40],"the":[41,67,80,100,151,164,173,189,227,238,266,275,278,284,293,296,305,318,339,343,385,416],"repeated":[42],"administration":[43],"of":[44,83,125,153,166,209,222,260,274,292,418],"low-dose":[45],"chemotherapy,":[46],"paclitaxel,":[49,120,297,323],"endorsed":[50],"an":[51,115],"antiangiogenic":[52],"effect":[53,411],"vitro,":[55,304],"and":[56,132,150,212,290,299,333,359,370],"because":[57],"trastuzumab":[58,126,174,203,253,311,379,390],"was":[59,373],"shown":[60],"to":[61,160,265,283,367],"inhibit":[62],"angiogenesis":[63,398],"tumor":[65,133,182,207,220],"xenografts,":[66],"authors":[68],"investigated":[69],"whether":[70],"ErbB-2-mediated":[71,397],"angiogenic":[72],"responses":[73],"would":[74],"be":[75,413],"inhibited":[76,396],"more":[77,375,394,406],"effectively":[78,376,395],"by":[79,98,377],"combined":[81,95,310,378],"treatment":[82,124,382,393,401],"plus":[85,127,175,312,380,391],"trastuzumab.":[86],"METHODS:":[87],"Tumor":[88],"xenografts":[89],"were":[90,112,137,156],"established":[91],"37":[93],"severe":[94],"immunodeficiency":[96],"mice":[97,186,213,276,294],"injecting":[99],"mammary":[101],"fat":[102],"pad":[103],"ErbB-2-overexpressing":[105,306],"human":[106],"breast":[107],"carcinoma":[108],"cells.":[109],"Mice":[110,170,200],"then":[111],"treated":[113,171,187,201,214,308,320],"immunoglobulin":[116],"(IgG)":[117],"control,":[118],"trastuzumab,":[119,298,322],"or":[121,324],"paclitaxel.":[128],"Tumorigenicity,":[129],"lung":[130],"metastasis,":[131],"microvessel":[134],"density":[135],"(MVD)":[136],"evaluated.":[138],"Vascular":[139],"endothelial":[140,145,349],"growth":[141],"factor":[142],"(VEGF)":[143],"secretion,":[144],"cell":[146,350],"migration":[147,351],"after":[148],"treatment,":[149],"status":[152],"phosphorylated":[154,419],"Akt":[155,364,371],"evaluated":[157],"vitro":[159],"determine":[161],"mechanisms":[162],"underlying":[163],"inhibition":[165],"ErbB-2-induced":[167],"angiogenesis.":[168],"RESULTS:":[169],"exhibited":[178],"significantly":[179,232],"reduced":[180,374],"mean":[181,206,219,234,348],"volumes":[183],"compared":[184,236,286,383],"IgG":[190],"control":[191,239,300,325],"(419.5":[192],"mm(3)":[193],"vs.":[194,244,328,354],"786.6":[195],"mm(3),":[196,211],"P":[197,249],"<":[198,250],"0.0001).":[199],"had":[204,217,231,255,281],"volume":[208,221],"543.9":[210],"574.9":[223],"mm(3).":[224],"Tumors":[225],"from":[226,342],"trastuzumab-plus-paclitaxel":[228,279],"group":[229,254,268,280,345],"also":[230],"decreased":[233],"MVD":[235,243,259],"(30":[240],"+/-":[241,246,262,270],"8":[242],"44":[245],"12":[247],"MVD,":[248],"0.05).":[251],"The":[252],"35":[261],"7,":[263],"similar":[264],"paclitaxel-treated":[267],"(35":[269],"9).":[271],"Forty-four":[272],"percent":[273],"metastases":[282],"lungs":[285],"50%,":[288],"63%,":[289],"75%":[291],"groups,":[301],"respectively.":[302],"In":[303,337],"cells":[307,319,353],"secreted":[314],"less":[315,347],"VEGF":[316,368],"than":[317,399],"(185.9":[326],"pg/mL":[327],"233.2":[329],"pg/mL,":[330,332,335],"261.3":[331],"286.4":[334],"respectively).":[336,362],"addition,":[338],"conditioned":[340],"media":[341],"stimulated":[346],"(31.0":[352],"47.0":[355],"cells,":[356,358,361],"39.2":[357],"67.5":[360],"Furthermore,":[363],"phosphorylation":[365,372],"contributed":[366],"up-regulation":[369],"treatments.":[387],"CONCLUSIONS:":[388],"Combined":[389],"either":[400],"alone,":[402],"which":[403],"resulted":[404],"pronounced":[407],"tumoricidal":[408],"effects.":[409],"This":[410],"may":[412],"mediated":[414],"via":[415],"reduction":[417],"Akt.":[420]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}